BridgeBio stock slides on discontinuation of CAH gene therapy Source: Seekingalpha
Browsing: therapy
BridgeBio stock slides on discontinuation of CAH gene therapy Source: Seekingalpha
BridgeBio gets FDA RMAT status for Canavan disease gene therapy Source: Seekingalpha
BridgeBio gets FDA RMAT status for Canavan disease gene therapy Source: Seekingalpha
BridgeBio gets FDA RMAT status for Canavan disease gene therapy Source: Seekingalpha
Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: Seekingalpha
Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: Seekingalpha
Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: Seekingalpha
Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: Seekingalpha
Novartis licenses gene therapy component from Voyager Source: Seekingalpha